Wachino Chiharu

Affiliation and department：
Other affiliations (1)：

Nagoya City University East Medical Center Clinical Pharmasit

Research keywords (7)： COVID-19 , ビックデータ , 感染症学・小児感染症 , 薬学教育 , レギュラトリーサイエンス , 臨床薬物動態学 , 薬理学

Research theme for competitive and other funds (4)：

2024 - 2027 COVID-19後遺症のリスク低減を目指したAIによるデータ駆動型予測システムの構築
2019 - 2024 小児領域の抗菌薬適正使用支援のための評価管理プログラムの開発と臨床実用化
2021 - 2022 医薬情報データベースと機械学習を融合した薬剤性腎障害の予測法の開発
2018 - 2019 小児領域の抗菌薬適正使用支援

Papers (14)：

Yasuhiro Horita, Minami Asaoka, Moeko Iida, Hideki Kato, Chiharu Wachino, Kana Mitamura, Kazuki Ohashi, Yoshihisa Mimura, Yuji Hotta, Tomoya Kataoka, et al. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication. Therapeutic drug monitoring. 2022. 45. 2. 245-250
Toshiki Etani, Minami Asaoka, Shuhei Kondo, Chiharu Wachino, Nami Tomiyama, Tatsuya Hattori, Takashi Nagai, Keitaro Iida, Kazumi Taguchi, Taku Naiki, et al. Efficacy of fosfomycin in preventing infection after endoscopic combined intrarenal surgery in periods of limited supply of first- and second-generation cephalosporins. International journal of urology : official journal of the Japanese Urological Association. 2022. 29. 9. 977-982
Minami Asaoka, Yasuhiro Horita, Chiharu Wachino, Shuhei Kondo, Yuji Hotta, Tomoya Kataoka, Akimasa Sanagawa, Tomoaki Hayakawa, Atsushi Nakamura, Kazunori Kimura. Clinical Usefulness of the "MN Criteria" - the <i>Clostridioides difficile</i> Infection Severity Scoring System - in the Japanese Setting. Internal Medicine. 2022
Toshiki Etani, Minami Asaoka, Shuhei Kondo, Chiharu Wachino, Kaoru Hori, Nobuhiko Shimizu, Yusuke Noda, Takashi Nagai, Satoshi Nozaki, Keitaro Iida, et al. Efficacy of fosfomycin in the prevention of postoperative infection following transurethral resection of bladder tumor during periods of limited cefazolin, cefotiam, and cefmetazole supply. JOURNAL OF INFECTION AND CHEMOTHERAPY. 2021. 27. 4. 625-631
田中創始, 朝岡みなみ, 堀田康弘, 和知野千春, 間辺利江, 中村敦. 特有な皮疹と嗅覚異常で診断した新型コロナウィルス感染症(COVID-19)の一例. 日本化学療法学会雑誌. 2021. 69. 2. 211-211

ｍore...

MISC (24)：

青木優佳, 安部賀央里, 頭金正博, 村島美穂, 濱野高行, 和知野千春, 和知野千春, 木村和哲, 日比陽子, 日比陽子, et al. 電子カルテ情報と機械学習を活用したシスプラチン誘発性急性腎障害の予測モデルの構築. 日本臨床薬理学会学術総会抄録集(Web). 2023. 44th
和知野千春, 中村敦, 田中創始, 加藤裕史, 山田紘史, 中村大学, 井口広靖, 柳田剛, 菱田純代. 多発性脳膿瘍の治療に難渋した中枢神経アスペルギルス症の一例. 日本化学療法学会雑誌. 2022. 70. Suppl.A. 296-296
惠谷俊紀, 朝岡みなみ, 和知野千春, 中村敦. セファゾリン供給困難に対する当科での対応と泌尿器科手術における臨床アウトカム. 日本化学療法学会雑誌. 2021. 69. Suppl.A. 233-233
朝岡みなみ, 中村敦, 堀田康弘, 早川智章, 和知野千春, 田中創始, 柳田剛, 真川明将, 片岡智哉, 堀田祐志, et al. MN基準の各スコアリング項目がClostridioides difficile感染症の重症化予測に与える影響. 日本化学療法学会雑誌. 2020. 68. Suppl.A. 312-312
朝岡みなみ, 田中創始, 和知野千春, 柳田剛, 中村敦, 近藤周平, 真川明将, 早川智章, 片岡智哉, 堀田康弘, et al. Clostridioides(Clostridium)difficile infection(CDI)の現状とこれから Clostridioides(Clostridium)difficile感染症の重症度判定. 日本化学療法学会雑誌. 2020. 68. 3. 411-412

ｍore...

Education (2)：

2005 - 2008 Nagasaki University Graduate School of Biomedical Sciences
2005 - 2007 The University of Iowa Department of Microbiology(研究留学)

Professional career (1)：

Doctor of Pharmacy (Nagasaki University Graduate School of Biomedical Science)

Work history (11)：

2023/07 - 現在 Nagoya City University East Medical Center Clinical Pharmasit
2023/07 - 現在 Nagoya City University Graduate School of Medical Sciences Department of Clinical Pharmaceutices & Therapeutices Assistant professor
2022/09 - 2023/06 Nagoya City University Graduate School of Medical Sciences Department of Clinical Pharmaceutices & Therapeutices Researcher
2018/02 - 2023/06 Nagoya City University Graduate School of Pharmaceutical Sciences Department of Hospital Pharmaceutics Researcher
2018/02 - 2023/06 Nagoya City University Hospital Department of Hospital Pharmacy Clinical Pharmacist

Show all

Committee career (1)：

2017 - 現在愛知県病院薬剤師会専門薬剤師教育委員会感染制御部会委員

Association Membership(s) (4)：

The Japanese Association for Infectious Diseases , Journal of Japanese Society of Hospital Pharmacists , Japanese Society of Pharmaceutical Health Care and Sciences, a General Incorporated Association , Japanese Society of Chemotherapy

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page